Infusion Pump Alert Segmentation and Autonomous Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Infusion pumps lack effective autonomous and manual control mechanisms for managing medication delivery, particularly in scenarios requiring precise adjustments based on patient-specific factors like food intake and insulin sensitivity, and they often generate disruptive alerts that can be distracting.

Innovation Solution

An infusion pump system that enables both autonomous and manual control, allowing users to enter and modify parameters, transfer operating parameters between devices, and temporarily disable disruptive alerts, using RFID readers and wireless communication to manage medication delivery based on user input and calculated bolus amounts.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If infusion pumps generate alerts to notify users of important events, then user awareness and safety are improved, but user distraction and disruption increase

Engineering Contradiction:
Improveuser awarenessVSAvoiduser distraction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The alert system is segmented into different types (disruptive vs. health alerts) with different behaviors. Disruptive alerts can be postponed during alert-free periods, while health alerts remain active and cannot be postponed. This segmentation allows the system to maintain safety awareness while reducing unnecessary distractions.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The alert system dynamically adjusts its behavior based on the current state. During alert-free periods, disruptive alerts are suppressed. The system transitions between states (alert-free period active/inactive) based on user requests, making the alert behavior dynamic rather than static.

Inventive Principle:
Principle #15Dynamics

2Measurement precision

If infusion pumps provide autonomous control with automated calculations, then medication delivery precision is improved, but device complexity increases

Engineering Contradiction:
Improvemedication delivery precisionVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The infusion pump performs automated calculations of bolus amounts based on user input (food intake, insulin sensitivity factors). The system serves itself by automatically processing user inputs and generating medication delivery parameters without requiring manual calculation by the user, thereby improving precision while keeping the interface simple.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system uses feedback loops where user inputs (food intake, insulin sensitivity) are processed through automated calculations, and the results are displayed for user confirmation. This feedback mechanism ensures precision while managing complexity through structured information flow.

Inventive Principle:
Principle #23Feedback

3Manufacturing precision

If infusion pumps require manual parameter entry for personalized treatment, then treatment accuracy is improved, but ease of operation deteriorates

Engineering Contradiction:
Improvetreatment accuracyVSAvoidease of operation
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

Users can pre-enter personal parameters (insulin sensitivity factors, target blood glucose levels) during setup. The system then uses these pre-entered values in automated calculations, reducing the need for frequent manual inputs while maintaining treatment accuracy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system acts as an intermediary by providing calculation tools and templates that process user inputs. Instead of requiring users to manually calculate bolus amounts, the system mediates between simple user inputs (food intake) and complex treatment parameters through automated calculations.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentEP3064236B1Method and system for manual and autonomous control of an infusion pump
Publication Date: 2020.02.05 BIGFOOT BIOMEDICAL INC
  • EP3064236B1 patent drawingFigure 1
  • EP3064236B1 patent drawingFigure 2
  • EP3064236B1 patent drawingFigure 3

AI summary

A method and system for both autonomous and manual control of an infusion pump for delivering medication to a patient is provided.